Connie Matsui
CIK: 0001236537
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jul 17, 2026ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Option (right to buy)
136 shares- - Jun 5, 2026STRO
SUTRO BIOPHARMA, INC.
Award(A)DirectStock Option (right to buy)
10K shares- - Jan 30, 2026ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Options (right to buy)
292 shares- - Dec 23, 2025STRO
SUTRO BIOPHARMA, INC.
Award(A)DirectStock Option (right to buy)
1.5K shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectWarrant (right to buy)
38.3K shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectConvertible Promissory Note
0 shares at avg. $110843.00- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectWarrant (right to buy)
70.4K shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectConvertible Promissory Note
0 shares at avg. $140000.00- - Oct 15, 2025STRO
SUTRO BIOPHARMA, INC.
Purchase(P)Direct50K shares at avg. $0.80$40K - Jun 6, 2025STRO
SUTRO BIOPHARMA, INC.
Award(A)DirectStock Option (right to buy)
50K shares- - May 1, 2025ARTL
ARTELO BIOSCIENCES, INC.
Purchase(P)DirectConvertible Promissory Note
0 shares at avg. $140000.00- - Dec 20, 2024ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Option (right to buy)
1.8K shares- - Nov 29, 2024HALO
HALOZYME THERAPEUTICS, INC.
Gift(G)Direct10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Option (right to buy) | 136 | - | - | Direct |
| Jun 5, 2026 |  STRO SUTRO BIOPHARMA, INC. | Award(A) Stock Option (right to buy) | 10,000 | - | - | Direct |
| Jan 30, 2026 | ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Options (right to buy) | 292 | - | - | Direct |
| Dec 23, 2025 | STRO SUTRO BIOPHARMA, INC. | Award(A) Stock Option (right to buy) | 1,500 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Warrant (right to buy) | 38,346 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Convertible Promissory Note | 0 | $110843.00 | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Warrant (right to buy) | 70,376 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Convertible Promissory Note | 0 | $140000.00 | - | Direct |
| Oct 15, 2025 | STRO SUTRO BIOPHARMA, INC. | Purchase(P) | 50,000 | $0.80 | $39,950 | Direct |
| Jun 6, 2025 | STRO SUTRO BIOPHARMA, INC. | Award(A) Stock Option (right to buy) | 50,000 | - | - | Direct |
| May 1, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Purchase(P) Convertible Promissory Note | 0 | $140000.00 | - | Direct |
| Dec 20, 2024 | ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Option (right to buy) | 1,750 | - | - | Direct |
| Nov 29, 2024 |  HALO HALOZYME THERAPEUTICS, INC. | Gift(G) | 10,470 | - | $0 | Direct |
1-13 of 13 transactions
About MATSUI CONNIE
MATSUI CONNIE (SEC CIK 0001236537) files insider reports with the SEC as Director of ARTELO BIOSCIENCES, INC. (ARTL), Director of SUTRO BIOPHARMA, INC. (STRO) and Director of HALOZYME THERAPEUTICS, INC. (HALO).
Signal8 holds 10 ownership filings by MATSUI CONNIE, all Form 4s, filed between Dec 3, 2024 and Jul 21, 2026. Those filings report 13 transactions, from Nov 29, 2024 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MATSUI CONNIE's filings is in SOLANA BEACH, CA.
Recent filings by MATSUI CONNIE
- Jul 17, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
- Jun 5, 2026: Grant or award of STRO derivative securities (Form 4, code A).
- Jan 30, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
- Dec 23, 2025: Grant or award of STRO derivative securities (Form 4, code A).
- Oct 28, 2025: Conversions of ARTL derivative securities (4 lines, Form 4, code C).
Other insiders filing for ARTELO BIOSCIENCES, INC. (ARTL)
- Blayney Douglas, Director
- Reyes Gregory, Director
- EMANUELE ROBERT MARTIN, Director
- Kelly Steven, Director
- FAVORITO TAMARA A, Director
- Spring Mark Edward, Chief Financial Officer